BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 28889388)

  • 1. Quantification of MicroRNAs in Urine-Derived Specimens.
    Fuessel S; Lohse-Fischer A; Vu Van D; Salomo K; Erdmann K; Wirth MP
    Methods Mol Biol; 2018; 1655():201-226. PubMed ID: 28889388
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Emerging Utility of Urinary Cell-free Nucleic Acid Biomarkers for Prostate, Bladder, and Renal Cancers.
    Lin SY; Linehan JA; Wilson TG; Hoon DSB
    Eur Urol Focus; 2017 Apr; 3(2-3):265-272. PubMed ID: 28753876
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A robust methodology to study urine microRNA as tumor marker: microRNA-126 and microRNA-182 are related to urinary bladder cancer.
    Hanke M; Hoefig K; Merz H; Feller AC; Kausch I; Jocham D; Warnecke JM; Sczakiel G
    Urol Oncol; 2010; 28(6):655-61. PubMed ID: 19375957
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantitative RNA Analysis from Urine Using Real Time PCR.
    Mengual L; Olivan M
    Methods Mol Biol; 2018; 1655():227-237. PubMed ID: 28889389
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of microRNAs in the urine of patients with bladder cancer.
    Wang G; Chan ES; Kwan BC; Li PK; Yip SK; Szeto CC; Ng CF
    Clin Genitourin Cancer; 2012 Jun; 10(2):106-13. PubMed ID: 22386240
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A microRNA biomarker panel for the non-invasive detection of bladder cancer.
    Urquidi V; Netherton M; Gomes-Giacoia E; Serie DJ; Eckel-Passow J; Rosser CJ; Goodison S
    Oncotarget; 2016 Dec; 7(52):86290-86299. PubMed ID: 27863434
    [TBL] [Abstract][Full Text] [Related]  

  • 7. mRNA, microRNA and lncRNA as novel bladder tumor markers.
    Wieczorek E; Reszka E
    Clin Chim Acta; 2018 Feb; 477():141-153. PubMed ID: 29224950
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Methylation of a panel of microRNA genes is a novel biomarker for detection of bladder cancer.
    Shimizu T; Suzuki H; Nojima M; Kitamura H; Yamamoto E; Maruyama R; Ashida M; Hatahira T; Kai M; Masumori N; Tokino T; Imai K; Tsukamoto T; Toyota M
    Eur Urol; 2013 Jun; 63(6):1091-100. PubMed ID: 23200812
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Direct quantitative detection for cell-free miR-155 in urine: a potential role in diagnosis and prognosis for non-muscle invasive bladder cancer.
    Zhang X; Zhang Y; Liu X; Fang A; Wang J; Yang Y; Wang L; Du L; Wang C
    Oncotarget; 2016 Jan; 7(3):3255-66. PubMed ID: 26657502
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Urine microRNAs as potential noninvasive biomarkers in urologic cancers.
    Mlcochova H; Hezova R; Stanik M; Slaby O
    Urol Oncol; 2014 Jan; 32(1):41.e1-9. PubMed ID: 24035473
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization and deep sequencing analysis of exosomal and non-exosomal miRNA in human urine.
    Cheng L; Sun X; Scicluna BJ; Coleman BM; Hill AF
    Kidney Int; 2014 Aug; 86(2):433-44. PubMed ID: 24352158
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of miR-182/miR-100 Ratio for Diagnosis and Survival Prediction in Bladder Cancer.
    Chen Z; Wu L; Lin Q; Shi J; Lin X; Shi L
    Arch Iran Med; 2016 Sep; 19(9):645-51. PubMed ID: 27631180
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Isolation and quantification of microRNAs from urinary exosomes/microvesicles for biomarker discovery.
    Lv LL; Cao Y; Liu D; Xu M; Liu H; Tang RN; Ma KL; Liu BC
    Int J Biol Sci; 2013; 9(10):1021-31. PubMed ID: 24250247
    [TBL] [Abstract][Full Text] [Related]  

  • 14. UBE2C cell-free RNA in urine can discriminate between bladder cancer and hematuria.
    Kim WT; Jeong P; Yan C; Kim YH; Lee IS; Kang HW; Kim YJ; Lee SC; Kim SJ; Kim YT; Moon SK; Choi YH; Kim IY; Yun SJ; Kim WJ
    Oncotarget; 2016 Sep; 7(36):58193-58202. PubMed ID: 27528424
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Urinary MicroRNAs as Potential Biomarkers of Bladder Cancer].
    Juráček J; Staník M; Peltanová B; Adamcová S; Doležel J; Fedorko M; Radová L; Slabý O
    Klin Onkol; 2018; 31(Supplementum1):155-157. PubMed ID: 29808692
    [TBL] [Abstract][Full Text] [Related]  

  • 16. miR-143, miR-222, and miR-452 are useful as tumor stratification and noninvasive diagnostic biomarkers for bladder cancer.
    Puerta-Gil P; García-Baquero R; Jia AY; Ocaña S; Alvarez-Múgica M; Alvarez-Ossorio JL; Cordon-Cardo C; Cava F; Sánchez-Carbayo M
    Am J Pathol; 2012 May; 180(5):1808-15. PubMed ID: 22426337
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnostic Value of Combination of MicroRNA-192 in Urinary Sediment and B-Ultrasound for Bladder Cancer.
    Jiang F; Li C; Han J; Wang L
    Technol Cancer Res Treat; 2020; 19():1533033819894573. PubMed ID: 32106776
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Urinary extracellular vesicles-encapsulated miRNA signatures: A new paradigm for urinary bladder cancer diagnosis and classification.
    Kural S; Jain G; Agarwal S; Das P; Kumar L
    Urol Oncol; 2024 Jul; 42(7):179-190. PubMed ID: 38594151
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MicroRNA molecular profiling from matched tumor and bio-fluids in bladder cancer.
    Armstrong DA; Green BB; Seigne JD; Schned AR; Marsit CJ
    Mol Cancer; 2015 Nov; 14():194. PubMed ID: 26576778
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The potential of circulating exosomal RNA biomarkers in cancer.
    Chu YL; Li H; Ng PLA; Kong ST; Zhang H; Lin Y; Tai WCS; Yu ACS; Yim AKY; Tsang HF; Cho WCS; Wong SCC
    Expert Rev Mol Diagn; 2020 Jul; 20(7):665-678. PubMed ID: 32188269
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.